Improving Genetic Counseling for BRCA+ Mothers
PCS IV
Parent Communication Study IV: Improving Genetic Counseling for BRCA+ Mothers
1 other identifier
interventional
200
1 country
1
Brief Summary
Genetic counseling and testing for hereditary breast cancer may reveal that you, and possibly your blood relatives, are at increased risk for the disease across the lifespan. This includes biological children, both male and female. We do not yet know the best ways to educate mothers who have a risk gene (are BRCA+) about whether, when, and how to share genetic information with their children or manage their thoughts and feelings. The purpose of this study is to help mothers make more informed choices about talking with children about hereditary breast cancer, provide them with age-and gender-appropriate information and emotional support, and improve their psychological well-being.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable breast-cancer
Started Jul 2020
Longer than P75 for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 4, 2020
CompletedFirst Posted
Study publicly available on registry
February 6, 2020
CompletedStudy Start
First participant enrolled
July 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2025
CompletedSeptember 27, 2024
September 1, 2024
5.5 years
February 4, 2020
September 25, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Communication
Parent-child and family communication of hereditary cancer risk.
1- and 6-months post-treatment
Study Arms (2)
Usual Care
ACTIVE COMPARATOREnhanced Care
EXPERIMENTALInterventions
Education includes a workbook, counseling includes peer support.
Eligibility Criteria
You may qualify if:
- Mothers/primary caregivers to adolescents/young adults ages 13-24 years-old.
- Participating in genetic testing for hereditary breast cancer.
- Adequately speak/read English.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
MedStar Georgetown University Hospital
Washington D.C., District of Columbia, 20007, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 4, 2020
First Posted
February 6, 2020
Study Start
July 1, 2020
Primary Completion
December 31, 2025
Study Completion
December 31, 2025
Last Updated
September 27, 2024
Record last verified: 2024-09